Neuronetics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neuronetics and other ETFs, options, and stocks.

About STIM

Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. 

CEO
Keith J. Sullivan
CEOKeith J. Sullivan
Employees
716
Employees716
Headquarters
Malvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded
1998
Founded1998
Employees
716
Employees716

STIM Key Statistics

Market cap
91.78M
Market cap91.78M
Price-Earnings ratio
-1.48
Price-Earnings ratio-1.48
Dividend yield
Dividend yield
Average volume
1.60M
Average volume1.60M
High today
$1.41
High today$1.41
Low today
$1.15
Low today$1.15
Open price
$1.20
Open price$1.20
Volume
2.42M
Volume2.42M
52 Week high
$5.34
52 Week high$5.34
52 Week low
$0.80
52 Week low$0.80

Stock Snapshot

As of today, Neuronetics(STIM) shares are valued at $1.34. The company's market cap stands at 91.78M, with a P/E ratio of -1.48.

During the trading session on 2026-03-18, Neuronetics(STIM) shares reached a daily high of $1.41 and a low of $1.15. At a current price of $1.34, the stock is +16.5% higher than the low and still -5.0% under the high.

Trading volume for Neuronetics(STIM) stock has reached 2.42M, versus its average volume of 1.6M.

The stock's 52-week range extends from a low of $0.80 to a high of $5.34.

The stock's 52-week range extends from a low of $0.80 to a high of $5.34.

STIM News

TipRanks 20h
Neuronetics files to sell 20.74M shares of common stock for holders

16:56 EDT Neuronetics (STIM) files to sell 20.74M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, market-movi...

Seeking Alpha 24h
Neuronetics outlines >9% 2026 revenue growth target while piloting new TMS models and preparing for Compass therapy launch

Earnings Call Insights Neuronetics outlines >9% 2026 revenue growth target while piloting new TMS models and preparing for Compass therapy launch Mar. 17, 2026...

Neuronetics outlines >9% 2026 revenue growth target while piloting new TMS models and preparing for Compass therapy launch
Nasdaq 1d
Neuronetics Q4 2025 Earnings Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

Neuronetics Q4 2025 Earnings Transcript

More STIM News

TipRanks 1d
Neuronetics Appoints New CEO to Lead Next Growth Phase

Neuronetics ( (STIM) ) has provided an update. On March 12, 2026, Neuronetics’ board appointed veteran medtech executive Daniel L. Reuvers as president and chi...

Nasdaq 1d
Neuronetics CEO Keith Sullivan To Step Down; Dan Reuvers Named Successor

(RTTNews) - Neuronetics Inc. (STIM), a Malvern, Pennsylvania-based medical technology company, on Tuesday announced that President and Chief Executive Officer K...

Neuronetics CEO Keith Sullivan To Step Down; Dan Reuvers Named Successor
TipRanks 1d
Neuronetics reports Q4 EPS (10c) vs. (34c) last year

Reports Q4 revenue $41.8M vs. $22.5M last year. “A year ago, we set out to build a vertically integrated mental health company, and I am proud of what this team...

TipRanks 1d
Neuronetics appoints Dan Reuvers as President and CEO

Neuronetics (STIM) appointed Dan Reuvers as the company’s next President and CEO, effective March 23. Reuvers will also join the Board of Directors at that time...

People also own

Based on the portfolios of people who own STIM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.